In vitro evaluation of isatin-pyridine oxime hybrids as potential acetylcholinesterase inhibitors for nerve agent prophylaxis
Status Publisher Language English Country Ireland Media print-electronic
Document type Journal Article
PubMed
40516590
DOI
10.1016/j.cbi.2025.111605
PII: S0009-2797(25)00235-2
Knihovny.cz E-resources
- Keywords
- Acetylcholinesterase, Alzheimer, Inhibition, Isatin, Neurodegenerative diseases, Organophosphorus, Reactivators,
- Publication type
- Journal Article MeSH
Given the recent deployment of nerve agents as a method of warfare and in targeted assassinations, the development of robust, broad-spectrum medical countermeasures is essential. Our research group has synthesized isatin-pyridine oxime hybrids that have previously demonstrated the ability to rescue Electrophorus eel acetylcholinesterase (EeAChE) inhibited by nerve agent surrogates. In this study, we investigated the in vitro AChE inhibitory properties of these hybrids by estimating their IC50 values. Compounds 14 and 15 exhibited inhibitory activity, with IC50 of 226.4 and 24.7 μM respectively. Notably, compound 15 showed a potency comparable to the reference compound pyridostigmine bromide, the only reported drug used prophylactically against nerve agent exposure. These results suggest promissing dual-functional compounds for nerve agent prophylaxis and potential reactivation of enzyme catalytic activity.
References provided by Crossref.org